Home Newsfeeds Evercore ISI Group Initiates Coverage On Legend Biotech with Outperform Rating

Evercore ISI Group Initiates Coverage On Legend Biotech with Outperform Rating

Evercore ISI Group analyst Umer Raffat initiates coverage on Legend Biotech (NASDAQ:LEGN) with a Outperform rating.

byBenzinga Newsdesk

November 2, 2022

1 minute read

Evercore ISI Group analyst Umer Raffat initiates coverage on Legend Biotech (NASDAQ:LEGN) with a Outperform rating.

BTIG Maintains Buy on CytomX Therapeutics, Lowers Price Target to $8

By Benzinga Newsdesk

July 7, 7:58 AM

BTIG analyst Kaveri Pohlman maintains CytomX Therapeutics (NASDAQ:CTMX) with a Buy and lowers the price target from $16 to $8.

CTMX

YanGuFang International Announces Ya Zhang Interim CEO And Yang Sui As Interim CFO, Effective As Of January 9, 2024

By Benzinga Newsdesk

January 11, 3:03 AM

The Company has been informed by the family members of Mr. Junguo He, the Chief Executive Officer (the "CEO") and Chairman of the Board of Directors (the "Board") of the Company, and Mr. Kui Shi, the

YGF

Citigroup Downgrades Sunlight Finl Hldgs to Sell, Lowers Price Target to $2

By Benzinga Newsdesk

September 29, 9:32 AM

Citigroup analyst Arren Cyganovich downgrades Sunlight Finl Hldgs (NYSE:SUNL) from Buy to Sell and lowers the price target from $4 to $2.

SUNL

Jefferies Initiates Coverage On Progress Software with Hold Rating, Announces Price Target of $52

By Benzinga Newsdesk

September 9, 4:47 AM

Jefferies analyst Brent Thill initiates coverage on Progress Software (NASDAQ:PRGS) with a Hold rating and announces Price Target of $52.

PRGS

Evercore ISI Group Initiates Coverage On Legend Biotech with Outperform Rating

Related Posts

BTIG Maintains Buy on CytomX Therapeutics, Lowers Price Target to $8

YanGuFang International Announces Ya Zhang Interim CEO And Yang Sui As Interim CFO, Effective As Of January 9, 2024

Citigroup Downgrades Sunlight Finl Hldgs to Sell, Lowers Price Target to $2

Jefferies Initiates Coverage On Progress Software with Hold Rating, Announces Price Target of $52